Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun 14;7:209.
doi: 10.3389/fphys.2016.00209. eCollection 2016.

Insights Into the Pathology of the α3 Na(+)/K(+)-ATPase Ion Pump in Neurological Disorders; Lessons From Animal Models

Affiliations
Free PMC article
Review

Insights Into the Pathology of the α3 Na(+)/K(+)-ATPase Ion Pump in Neurological Disorders; Lessons From Animal Models

Thomas H Holm et al. Front Physiol. .
Free PMC article

Abstract

The transmembrane Na(+)-/K(+) ATPase is located at the plasma membrane of all mammalian cells. The Na(+)-/K(+) ATPase utilizes energy from ATP hydrolysis to extrude three Na(+) cations and import two K(+) cations into the cell. The minimum constellation for an active Na(+)-/K(+) ATPase is one alpha (α) and one beta (β) subunit. Mammals express four α isoforms (α1-4), encoded by the ATP1A1-4 genes, respectively. The α1 isoform is ubiquitously expressed in the adult central nervous system (CNS) whereas α2 primarily is expressed in astrocytes and α3 in neurons. Na(+) and K(+) are the principal ions involved in action potential propagation during neuronal depolarization. The α1 and α3 Na(+)-/K(+) ATPases are therefore prime candidates for restoring neuronal membrane potential after depolarization and for maintaining neuronal excitability. The α3 isoform has approximately four-fold lower Na(+) affinity compared to α1 and is specifically required for rapid restoration of large transient increases in [Na(+)]i. Conditions associated with α3 deficiency are therefore likely aggravated by suprathreshold neuronal activity. The α3 isoform been suggested to support re-uptake of neurotransmitters. These processes are required for normal brain activity, and in fact autosomal dominant de novo mutations in ATP1A3 encoding the α3 isoform has been found to cause the three neurological diseases Rapid Onset Dystonia Parkinsonism (RDP), Alternating Hemiplegia of Childhood (AHC), and Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS). All three diseases cause acute onset of neurological symptoms, but the predominant neurological manifestations differ with particularly early onset of hemiplegic/dystonic episodes and mental decline in AHC, ataxic encephalopathy and impairment of vision and hearing in CAPOS syndrome and late onset of dystonia/parkinsonism in RDP. Several mouse models have been generated to study the in vivo consequences of Atp1a3 modulation. The different mice show varying degrees of hyperactivity, gait problems, and learning disability as well as stress-induced seizures. With the advent of several Atp1a3-gene or chemically modified animal models that closely phenocopy many aspects of the human disorders, we will be able to reach a much better understanding of the etiology of RDP, AHC, and CAPOS syndrome.

Keywords: alternating hemiplegia of childhood (AHC) and cerebellar ataxia; and sensorineural hearing loss (CAPOS); areflexia; mouse models; neurons; optic atrophy; pes cavus; rapid onset dystonia parkinsonism (RDP); α3 sodium ion pump.

Similar articles

See all similar articles

Cited by 13 articles

See all "Cited by" articles

References

    1. Ackermann T. F., Kempe D. S., Lang F., Lang U. E. (2010). Hyperactivity and enhanced curiosity of mice expressing PKB/SGK-resistant glycogen synthase kinase-3 (GSK-3). Cell. Physiol. Biochem. 25, 775–786. 10.1159/000315097 - DOI - PubMed
    1. Alonso E., Cano-Abad M. F., Moreno-Ortega A. J., Novalbos J., Milla J., García A. G., et al. . (2013). Nanomolar ouabain elicits apoptosis through a direct action on HeLa cell mitochondria. Steroids 78, 1110–1118. 10.1016/j.steroids.2013.07.010 - DOI - PubMed
    1. Aminian A., Strashun A., Rose A. (1993). Alternating hemiplegia of childhood: studies of regional cerebral blood flow using 99mTc-hexamethylpropylene amine oxime single-photon emission computed tomography. Ann. Neurol. 33, 43–47. 10.1002/ana.410330108 - DOI - PubMed
    1. Araujo B., Torres L., Stein M., Cabral F. R., Herai R., Okamoto O., et al. . (2014). Decreased expression of proteins involved in energy metabolism in the hippocampal granular layer of rats submitted to the pilocarpine epilepsy model. Neurosci. Lett. 561, 46–51. 10.1016/j.neulet.2013.12.040 - DOI - PubMed
    1. Attwell D., Laughlin S. B. (2001). An energy budget for signaling in the grey matter of the brain. J. Cereb. Blood Flow Metab. 21, 1133–1145. 10.1097/00004647-200110000-00001 - DOI - PubMed

LinkOut - more resources

Feedback